Côte d'Ivoire vs Ghana: Number of people requiring preventive treatment for schistosomiasis
Côte d'Ivoire
8.30 million people
in 2024
Ghana
8.31 million people
in 2024
Côte d'Ivoire rank
10th
Ghana rank
9th
Number of people requiring preventive treatment for schistosomiasis over time
- Côte d'Ivoire
- Ghana
How they compare
Ghana currently reports 8.31 million people against 8.30 million people in Côte d'Ivoire, a difference of 1,760 people.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Ghana ahead.
Côte d'Ivoire ranks 10th and Ghana ranks 9th of 52 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.22 million people | 8.62 million people | 4.40 million people | Ghana |
| 2020s | 6.94 million people | 10.10 million people | 3.16 million people | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people requiring preventive treatment for schistosomiasis, Côte d'Ivoire or Ghana?
- Ghana, at 8.31 million people against 8.30 million people in Côte d'Ivoire as of 2024.
- What is the difference in number of people requiring preventive treatment for schistosomiasis between Côte d'Ivoire and Ghana?
- 1,760 people, with Ghana ahead.
- How many years of comparable data are there for Côte d'Ivoire and Ghana?
- 15 years are reported by both, from 2010 to 2024.
- How do Côte d'Ivoire and Ghana rank globally for number of people requiring preventive treatment for schistosomiasis?
- Côte d'Ivoire ranks 10th and Ghana ranks 9th of 52 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Number of people requiring preventive treatment for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Population requiring preventive chemotherapy for schistosomiasis.